These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 9841829

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A, Giraldo A, Castañeda E, Martínez M, de la Hoz F, Rivas F, Depetris A, Svennerholm AM, Sack DA.
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A review of the current status of enteric vaccines.
    Levine MM, Noriega F.
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants.
    Savarino SJ, Hall ER, Bassily S, Wierzba TF, Youssef FG, Peruski LF, Abu-Elyazeed R, Rao M, Francis WM, El Mohamady H, Safwat M, Naficy AB, Svennerholm AM, Jertborn M, Lee YJ, Clemens JD, Pride Study Group.
    Pediatr Infect Dis J; 2002 Apr; 21(4):322-30. PubMed ID: 12075764
    [Abstract] [Full Text] [Related]

  • 9. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
    Dima VF, Ionescu MD, Palade R, Balotescu C, Becheanu G, Dima SV.
    Roum Arch Microbiol Immunol; 2001 Apr; 60(1):27-54. PubMed ID: 11850896
    [Abstract] [Full Text] [Related]

  • 10. Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2-5-year-old children.
    Ahmed A, Li J, Shiloach Y, Robbins JB, Szu SC.
    J Infect Dis; 2006 Feb 15; 193(4):515-21. PubMed ID: 16425130
    [Abstract] [Full Text] [Related]

  • 11. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children.
    Qadri F, Wennerâs C, Ahmed F, Asaduzzaman M, Saha D, Albert MJ, Sack RB, Svennerholm A.
    Vaccine; 2000 Jun 01; 18(24):2704-12. PubMed ID: 10781858
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
    Tobias J, Svennerholm AM, Carlin NI, Lebens M, Holmgren J.
    Vaccine; 2011 Nov 08; 29(48):8863-9. PubMed ID: 21983363
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
    Roland KL, Cloninger C, Kochi SK, Thomas LJ, Tinge SA, Rouskey C, Killeen KP.
    Vaccine; 2007 Dec 12; 25(51):8574-84. PubMed ID: 18045752
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults.
    McKenzie R, Bourgeois AL, Engstrom F, Hall E, Chang HS, Gomes JG, Kyle JL, Cassels F, Turner AK, Randall R, Darsley M, Lee C, Bedford P, Shimko J, Sack DA.
    Infect Immun; 2006 Feb 12; 74(2):994-1000. PubMed ID: 16428745
    [Abstract] [Full Text] [Related]

  • 20. Safety, tolerability, and immunogenicity of an oral inactivated ETEC vaccine (ETVAX®) with dmLT adjuvant in healthy adults and children in Zambia: An age descending randomised, placebo-controlled trial.
    Sukwa N, Mubanga C, Hatyoka LM, Chilyabanyama ON, Chibuye M, Mundia S, Munyinda M, Kamuti E, Siyambango M, Badiozzaman S, Bosomprah S, Carlin N, Kaim J, Sjöstrand B, Simuyandi M, Chilengi R, Svennerholm AM.
    Vaccine; 2023 Nov 02; 41(46):6884-6894. PubMed ID: 37838479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.